CORZ
Core Scientific, Inc.
Stock
$16.45+0.10 (+0.61%)Close Oct 2, 2026
Cash flow statement
| Line | Last 12 months | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Operating cash flow | $520M | $278M | $43M | $65M | $205M | −$57M | −$24M |
| Capital expenditures | $1.5B | $729M | $95M | $16M | $384M | $0 | $0 |
| Free cash flow | −$958M | −$451M | −$52M | $49M | −$179M | −$57M | −$24M |
| Stock-based compensation | $94M | $98M | $52M | $59M | $183M | $39M | $3.0M |
| Buybacks | — | — | $0 | $0 | $32M | — | — |
| Free cash flow margin | −217.5% | −141.3% | −10.2% | 9.7% | −27.9% | −10.4% | −39.4% |